Article
Licensed
Unlicensed
Requires Authentication
Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
-
David Prvulovic
Published/Copyright:
February 23, 2011
Abstract
A growing body of evidence suggests that Alzheimer's disease (AD) is a multifactorial disease resulting in the well-known, common neuropathological pathway characterized by extracellular fibrillar β amyloid (Aβ) deposits in the brain, intracellular neurofibrillary tangles (NFT) and neuronal as well as axonal degeneration. While fairly accurate, the clinical diagnosis of probable AD based on standard diagnostic criteria does not take into account the long preclinical and prodromal course of AD. AD-related pathophysiological changes can occur many years and even decades before the appearance of clinical dementia syndrome. Biomarkers that are related to the pathophysiology of AD may thus help detect the preclinical stages of disease, and improve early and differential diagnosis. Here, we provide an overview of current literature on the core AD biomarkers, Aβ and phosphor-tau (p-tau), on different methods and modalities of assessing them [e.g., cerebrospinal fluid (CSF) analysis and PET imaging], and on their diagnostic and predictive value in preclinical and clinical stages of AD.
Keywords: Alzheimer's disease; beta amyloid; intracellular neurofibrillary tangles; neuropathological pathway; p-tau
Received: 2010-11-11
Accepted: 2011;-1-19
Published Online: 2011-02-23
Published in Print: 2011-03-01
©2011 by Walter de Gruyter Berlin New York
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Editorial
- Biomarkers of neurodegenerative diseases
- Reviews
- CSF biomarkers in neurodegenerative diseases
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
- The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
- Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
- Parkinson's disease – the continuing search for biomarkers
- α-Synuclein in Parkinson disease and other neurodegenerative disorders
- S100B protein in neurodegenerative disorders
- Inflammatory and structural biomarkers in acute traumatic spinal cord injury
- Homocysteine: a biomarker in neurodegenerative diseases
- Editorial
- ROMA or death: advances in epithelial ovarian cancer diagnosis
- Review
- Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays
- General Clinical Chemistry and Laboratory Medicine
- Quality indicators and specifications for key analytical-extranalytical processes in the clinical laboratory. Five years’ experience using the Six Sigma concept
- Determination of oxidative and occupational stress in palliative care workers
- Effect of cigarette smoking on plasma homocysteine concentrations
- Erythrocyte membrane protein analysis by sodium dodecyl sulphate-capillary gel electrophoresis in the diagnosis of hereditary spherocytosis
- Evaluation of hematological parameters on admission for the prediction of 7-day in-hospital mortality in a large trauma cohort
- Platelet function testing in hirudin and BAPA anticoagulated blood
- Evaluation of the iChem® Velocity™ Urine Chemistry Analyzer in a hospital routine laboratory
- Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy
- Cancer Diagnostics
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population
- Cardiovascular Diseases
- APOA5 −1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis
- Assessment of the nickel-albumin binding assay for diagnosis of acute coronary syndrome
- Letters to the Editor
- AGER gene -374T>A (rs1800624) polymorphism is not associated with the severity of non-diabetic coronary artery disease in Han Chinese
- Some lessons learned from using medium scale genotyping techniques in pharmacogenetic research
- Improved neopterin ELISA kit: a good compromise between HPLC results and clinical practice
- Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples
- Modulated human maternal and premature neonatal erythrocyte membrane enzyme activities in relation to the mode of delivery: in vitro restoration with L-Carnitine
Keywords for this article
Alzheimer's disease;
beta amyloid;
intracellular neurofibrillary tangles;
neuropathological pathway;
p-tau
Articles in the same Issue
- Editorial
- Biomarkers of neurodegenerative diseases
- Reviews
- CSF biomarkers in neurodegenerative diseases
- Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
- Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease
- The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis, tau pathology and neurodegeneration in Alzheimer's disease
- Advanced glycation endproducts as gerontotoxins and biomarkers for carbonyl-based degenerative processes in Alzheimer's disease
- Parkinson's disease – the continuing search for biomarkers
- α-Synuclein in Parkinson disease and other neurodegenerative disorders
- S100B protein in neurodegenerative disorders
- Inflammatory and structural biomarkers in acute traumatic spinal cord injury
- Homocysteine: a biomarker in neurodegenerative diseases
- Editorial
- ROMA or death: advances in epithelial ovarian cancer diagnosis
- Review
- Laboratory testing for the antiphospholipid syndrome: making sense of antiphospholipid antibody assays
- General Clinical Chemistry and Laboratory Medicine
- Quality indicators and specifications for key analytical-extranalytical processes in the clinical laboratory. Five years’ experience using the Six Sigma concept
- Determination of oxidative and occupational stress in palliative care workers
- Effect of cigarette smoking on plasma homocysteine concentrations
- Erythrocyte membrane protein analysis by sodium dodecyl sulphate-capillary gel electrophoresis in the diagnosis of hereditary spherocytosis
- Evaluation of hematological parameters on admission for the prediction of 7-day in-hospital mortality in a large trauma cohort
- Platelet function testing in hirudin and BAPA anticoagulated blood
- Evaluation of the iChem® Velocity™ Urine Chemistry Analyzer in a hospital routine laboratory
- Crystalluria: prevalence, different types of crystals and the role of infrared spectroscopy
- Cancer Diagnostics
- The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
- Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population
- Cardiovascular Diseases
- APOA5 −1131T/C polymorphism is associated with coronary artery disease in a Chinese population: a meta-analysis
- Assessment of the nickel-albumin binding assay for diagnosis of acute coronary syndrome
- Letters to the Editor
- AGER gene -374T>A (rs1800624) polymorphism is not associated with the severity of non-diabetic coronary artery disease in Han Chinese
- Some lessons learned from using medium scale genotyping techniques in pharmacogenetic research
- Improved neopterin ELISA kit: a good compromise between HPLC results and clinical practice
- Cross-reactivity of 25-hydroxy vitamin D2 from different commercial immunoassays for 25-hydroxy vitamin D: an evaluation without spiked samples
- Modulated human maternal and premature neonatal erythrocyte membrane enzyme activities in relation to the mode of delivery: in vitro restoration with L-Carnitine
